Yahoo
NYSE USD

Bio-Rad Laboratories, Inc. (BIO)

372.18 -12.22 (-3.18%)
At close: October 30 at 4:00:02 PM EDT
372.18 0.00 (0.00%)
After hours: October 30 at 4:00:59 PM EDT
Trade BIO on Coinbase

Key Executives

Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name Title Pay Exercised Year Born
Mr. Norman D. Schwartz
Chairman & CEO 1.68M -- 1950
Mr. Jonathan P. DiVincenzo
President & COO 1.17M -- 1966
Mr. Roop K. Lakkaraju CPA
Executive VP & CFO 984.42k -- 1971
Mr. James J. Barry
Executive VP & President of Life Science Group 1.11M -- 1978
Mr. Rajat Mehta
Executive Vice President of Global Commercial Operations 829.47k -- 1979
Mr. Ruben Argueta
Vice President of Investor Relations -- -- --
Matthew Werner
Senior VP and Chief Compliance & Privacy Officer -- -- --
Ms. Courtney C. Enloe
Executive VP, General Counsel & Secretary -- -- 1972
Ms. Nanditha R. Yelamanchi
Executive Vice President of Global Human Resources -- -- --
Mr. Michael Crowley
Executive Vice President of Global Commercial Operations 649.8k 360.07k 1962

Bio-Rad Laboratories, Inc.

1000 Alfred Nobel Drive
Hercules, CA 94547
United States
510 724 7000 https://www.bio-rad.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
7,450

Description

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Corporate Governance

Bio-Rad Laboratories, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 4, 2026 at 9:00 PM UTC

Bio-Rad Laboratories, Inc. Earnings Date

Recent Events

August 4, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

May 13, 2026 at 12:00 AM UTC

SD: Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)

April 30, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

April 24, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 25, 2026 at 12:00 AM UTC

ARS: Annual Report to Shareholders

February 19, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

February 13, 2026 at 12:00 AM UTC

10-K: Periodic Financial Reports

February 12, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

October 29, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

September 30, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: